Notice of Closed Meeting, 16358 [2018-07817]
Download as PDF
<![CDATA[
16358
Federal Register / Vol. 83, No. 73 / Monday, April 16, 2018 / Notices
srobinson on DSK3G9T082PROD with NOTICES
Form Numbers: Agent Notice of
Delegation #5900–172, Certificate of
Representation #7610–1, General
Account Form #7610–5, Allowance
Transfer Form #7610–6, Retired Unit
Exemption #7610–20, Allowance
Deduction #7620–4.
Respondents/affected entities:
Industry respondents are stationary,
fossil fuel-fired boilers and combustion
turbines serving electricity generators
subject to the CSAPR and Texas trading
programs, as well as non-source entities
voluntarily participating in allowance
trading activities. Potential state
respondents are states that can elect to
submit state-determined allowance
allocations for sources located in their
states.
Respondents’ obligation to respond:
Industry respondents: Voluntary and
mandatory (Sections 110(a) and 301(a)
of the Clean Air Act). State respondents:
Voluntary.
Estimated number of respondents:
EPA estimates that there are 1,028
industry respondents, including 978
affected sources and 50 non-source
entities participating in allowance
trading activities, and 27 potential state
respondents.
Frequency of response: On occasion,
quarterly, and annually.
Total estimated burden: 134,423
hours (per year). Burden is defined at 5
CFR 1320.03(b).
Total estimated cost: $18,563,878 (per
year); includes $8,207,545 annualized
capital or operation & maintenance
costs.
Changes in Estimates: There is
decrease of 40,699 hours in the total
estimated respondent burden compared
with the ICR currently approved by
OMB. This decrease is due almost
entirely to adjustments in the estimated
numbers of respondents and
transactions and the time required to
complete certain activities. Changes in
programs—i.e., the removal of Texas
units from two CSAPR trading programs
and the start of the Texas SO2 Trading
Program—together are responsible for
approximately 574 hours of the overall
decrease.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention (CDC)—Health Disparities
Subcommittee (HDS)
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Management Analysis and
Services Office, CDC, pursuant to Public
Law 92–463. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease, Disability,
and Injury Prevention and Control Special
Emphasis Panel (SEP) IP18–004, Public
Health Epidemiology of Influenza Virus
Infection and Control in China.
Date: June 5, 2018.
Time: 10:00 a.m.–3:00 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact: Gregory
Anderson, M.S., M.P.H., Scientific Review
Officer, CDC, 1600 Clifton Road NE, Mailstop
E60, Atlanta, Georgia 30329, (404) 718–8833,
gca5@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2018–07817 Filed 4–13–18; 8:45 am]
BILLING CODE 4163–18–P
Dated: April 3, 2018.
Reid P. Harvey,
Director, Clean Air Markets Division, Office
of Atmospheric Programs, Office of Air and
Radiation.
[FR Doc. 2018–07887 Filed 4–13–18; 8:45 am]
BILLING CODE 6560–50–P
VerDate Sep<11>2014
19:42 Apr 13, 2018
Jkt 244001
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
AGENCY:
ACTION:
Notice of meeting.
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Advisory Committee to the
Director, Centers for Disease Control
and Prevention—Health Disparities
Subcommittee (ACD, CDC–HDS). This
meeting is open to the public, limited
only by the by the space and phone
lines available. The public is also
welcome to listen to the meeting by
teleconference call in number is (866)
918–8397 and enter code 9346283. The
public comment period is from 12:45
p.m.–12:50 p.m.
SUMMARY:
The meeting will be held on May
23, 2018, 11:00 a.m. to 1:00 p.m., EST.
DATES:
This meeting will be held
via teleconference. Please dial (866)
918–8397 and enter code 9346283.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Leandris Liburd, Ph.D., M.P.H., M.A.,
Designated Federal Officer, Health
Disparities Subcommittee, Advisory
Committee to the Director, CDC, 1600
Clifton Road NE, M/S K–77, Atlanta,
Georgia 30329. Telephone (404) 498–
6482, Email: ACDirector@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Subcommittee will
provide counsel to the CDC Director
through the ACD on strategic and other
health disparities and health equity
issues and provide guidance on
opportunities for CDC.
Matters to be Considered: The agenda
will include discussions and a status
report on the Health Equity Leadership
Network (HELN). Agenda items are
subject to change as priorities dictate.
Agenda items are subject to change as
priorities dictate.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
E:\FR\FM\16APN1.SGM
16APN1
]]>Agencies
[Federal Register Volume 83, Number 73 (Monday, April 16, 2018)]
[Notices]
[Page 16358]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-07817]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended, and the Determination of the Director, Management
Analysis and Services Office, CDC, pursuant to Public Law 92-463. The
grant applications and the discussions could disclose confidential
trade secrets or commercial property such as patentable material, and
personal information concerning individuals associated with the grant
applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention
and Control Special Emphasis Panel (SEP) IP18-004, Public Health
Epidemiology of Influenza Virus Infection and Control in China.
Date: June 5, 2018.
Time: 10:00 a.m.-3:00 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, 1600 Clifton Road NE, Mailstop E60,
Atlanta, Georgia 30329, (404) 718-8833, [email protected].
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Elaine Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2018-07817 Filed 4-13-18; 8:45 am]
BILLING CODE 4163-18-P
